10 Results for "

B. anthracis

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "B. anthracis" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B1831A
CAS No.: 192564-14-0
Synonyms: LY333328 diphosphate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Inflammation/Immunology

Oritavancin diphosphate (LY333328 diphosphate), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin diphosphate inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin diphosphate inhibits ArlS kinase activity thereby interfering the signal transduction. Oritavancin diphosphate enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-76260
CAS No.: 122547-49-3
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Faropenem sodium is an orally bioavailable penem antibiotic. Faropenem sodium regulates inorganic phosphate transporter Npt1. Faropenem sodium inhibits M. tuberculosis (MIC of 1.3 μg/mL) and B. anthracis .
loading...
    loading...
Cat. No.: HY-N2567
CAS No.: 5993-18-0
Synonyms: (±)-Aegelinol; (±)-Smyrinol
(±)-Decursinol is a potent FtsZ inhibitor. (±)-Decursinol inhibits B. anthracis FtsZ polymerization with an IC50 of 102 μM .
loading...
    loading...
Cat. No.: HY-B1831
CAS No.: 171099-57-3
Synonyms: LY 333328; Orbactiv
Target:  

Antibiotic Bacterial

Research Areas:  

Infection Inflammation/Immunology

Oritavancin (LY 333328), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin inhibits ArlS kinase activity thereby interfering the signal transduction. Oritavancin enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .
loading...
    loading...
Cat. No.: HY-P5548
CAS No.: 1228093-67-1
Target:  

Bacterial

Research Areas:  

Infection Cancer

CaLL is an antimicrobial peptide. CaLL has antibacterial activity against B. anthracis, B. anthracis (vegetative), and B. cepacia (MIC: 7.8, 31.3, 31.3 μg/mL) .
loading...
    loading...
Cat. No.: HY-P5691
CAS No.: 675123-75-8
Target:  

Bacterial

Research Areas:  

Infection Cancer

P1 is a broad-spectrum antimicrobial peptide. P1 shows antibacterial activity against Gram-positive and Gram-negative bacteria,such as B. anthracis spores and Carbapenem-resistant A. baumannii and K. pneumoniae .
loading...
    loading...
Cat. No.: HY-136943
CAS No.: 53026-37-2
K-41 is an orally active antibiotic. K-41 can be obtained from Streptomyces hygroscopicus. K-41 has antibacterial and antiplasmodial activity .
loading...
    loading...
Cat. No.: HY-B1831AR
CAS No.: 192564-14-0
Synonyms: LY333328 diphosphate (Standard)
Oritavancin (diphosphate) (Standard) is the analytical standard of Oritavancin (diphosphate). Oritavancin diphosphate (Standard), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin diphosphate (Standard) shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin diphosphate (Standard) inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin diphosphate (Standard) inhibits ArlS kinase activity thereby interfering the signal transduction. Oritavancin diphosphate (Standard) enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .
loading...
    loading...
Cat. No.: HY-115442
CAS No.: 106359-61-9
Target:  

HDAC Bacterial

Research Areas:  

Infection Cancer

NHNB is a selective HDAC8 inhibitor (IC50 = 66.0 μM) and Peptidoglycan N-acetylglucosamine (GlcNAc) deacetylases (PGNGdacs) inhibitor. NHNB shows antibacterial and bactericidal activity against B. anthracis and B. cereus. NHNB can be used for the research of acute myeloid leukemia, Bacillus anthracis infection, and Bacillus cereus infection .
loading...
    loading...
Cat. No.: HY-76260S
Faropenem-d7 sodium is the deuterium labeled Faropenem sodium (HY-76260). Faropenem sodium is an orally bioavailable penem antibiotic. Faropenem sodium regulates inorganic phosphate transporter Npt1. Faropenem sodium inhibits M. tuberculosis (MIC of 1.3 μg/mL) and B. anthracis .
loading...
    loading...